| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/22/2001 | CA2383922A1 Cytokine receptor common gamma chain like |
| 02/22/2001 | CA2383691A1 Human tumor necrosis factor receptor tr16 |
| 02/22/2001 | CA2382251A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 02/22/2001 | CA2382148A1 25 human secreted proteins |
| 02/22/2001 | CA2382018A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | CA2382015A1 Membrane associated proteins |
| 02/22/2001 | CA2381979A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 02/22/2001 | CA2381863A1 Novel transcription factor, bp1 |
| 02/22/2001 | CA2381794A1 Helical cytokine zalpha48 |
| 02/22/2001 | CA2381706A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 02/22/2001 | CA2380888A1 Treatment of metastatic disease |
| 02/21/2001 | EP1077263A1 Process for producing natural folded and secreted proteins by co-secretion of chaperones |
| 02/21/2001 | EP1077262A1 Process for the production of naturally folded and secreted proteins by co-secretion of molecular shaperones |
| 02/21/2001 | EP1077219A1 Transcriptional regulatory factor |
| 02/21/2001 | EP1077217A2 Neuroactive peptides and their use |
| 02/21/2001 | EP1077068A1 Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 02/21/2001 | EP1076711A2 Human apoptosis associated proteins |
| 02/21/2001 | EP1076707A1 PLASMID FOR GENE EXPRESSION IN $i(PICHIA CIFERRII) AND TRANSFORMATION METHOD USING THE SAME |
| 02/21/2001 | EP1076703A2 Il-17 homologous polypeptides and therapeutic uses thereof |
| 02/21/2001 | EP1076702A1 Human protease associated proteins |
| 02/21/2001 | EP1076700A2 Human nucleic acid sequences obtained from pancreas tumor tissue |
| 02/21/2001 | EP1076698A2 Transgenic plant-derived human blood coagulation factors |
| 02/21/2001 | EP1076696A2 Human receptor molecules |
| 02/21/2001 | EP1076662A2 Polyepitope carrier protein |
| 02/21/2001 | EP0871470A4 Haemopoietic growth factor antagonists and uses therefor |
| 02/21/2001 | EP0784683B1 Tie-2 ligands, methods of making and uses thereof |
| 02/21/2001 | EP0725825B1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains |
| 02/21/2001 | EP0527852B2 Method and compositions for treating injury |
| 02/21/2001 | EP0526452B1 Hybrid immunoglobulins |
| 02/21/2001 | CN1284995A Tissue cement proteins from rhipicephalus appendiculatus |
| 02/21/2001 | CN1284965A Novel surface protein of i (neisseria meningitidis) |
| 02/21/2001 | CN1284962A Isolated nucleic acid molecules which encode TAGE molecules, and uses thereof |
| 02/21/2001 | CN1284882A Beta-lipotropin and uses thereof |
| 02/21/2001 | CN1284566A Preparation process of Lidamycin as one antineoplastic antibiotics |
| 02/21/2001 | CN1062312C Type IV collagenase-resisting single chain antibody |
| 02/21/2001 | CN1062311C Fused gene of IL-2 derivatives and ANP derivatives, protein products and their application thereof |
| 02/21/2001 | CN1062306C Microzyme Cu-metallothionein and its production |
| 02/21/2001 | CN1062274C Alpha derivative of human tumor necrosin and its preparation |
| 02/20/2001 | US6191270 Nucleotide sequences coding plasmodium protein; for prevention and immunization against plasmodium infection |
| 02/20/2001 | US6191268 Nucleotide sequence coding human maintenance protein; for the detection and treatment of tumors; for the detection of oncogenes |
| 02/20/2001 | US6191267 Cloning and producing the N.BstNBI nicking endonuclease |
| 02/20/2001 | US6191261 Immunoglobulin that preferential binds a growth factor; for the diagnosis and treatment of cell proliferative defects; antiproliferative agents |
| 02/20/2001 | US6191258 Polypeptide which associates with symetric nucleotide sequences; for the artificial regulation of gene expression in plants |
| 02/20/2001 | US6191255 Isolated matrix metalloproteinase of given amino acid sequence having the activation capability of pro-matrix metalloproteinase 2; vectors; transformed cells; use in diagnosis of cancer |
| 02/20/2001 | US6191254 Of given amino acid sequences |
| 02/20/2001 | US6191104 Methods of treating graft rejection with the IL-17 receptor |
| 02/20/2001 | US6190908 Modulation of polypeptide display on modified filamentous phage |
| 02/20/2001 | US6190905 Cleaning contact lens; incubating contact lens with proteolytic enzyme, wash several times in buffer, store for utilization |
| 02/20/2001 | US6190901 Chicken interleukin-15 and uses thereof |
| 02/20/2001 | US6190897 Nucleotide sequence coding hydrolase; for use in digestion of animal feeds |
| 02/20/2001 | US6190887 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein |
| 02/20/2001 | US6190886 Trimerizing polypeptides, their manufacture and use |
| 02/20/2001 | US6190883 Method for the production of heterologous polypeptides in transformed yeast cells |
| 02/20/2001 | US6190880 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 02/20/2001 | US6190876 KUZ, a novel family of metalloproteases |
| 02/20/2001 | US6190871 Determining efficacy of monoclonal antibody to neutralize primary isolates by culturing various concentrations of antibody with virus and h9 cells, determining concentration of p24 antigen as indicator of infection, and comparing |
| 02/20/2001 | US6190860 Method to detect CMV by hybridization with a gp55 specific DNA probe |
| 02/20/2001 | US6190723 Neutralization of food allergens by thioredoxin |
| 02/20/2001 | US6190668 Providing cell mass of moraxella catarrhalis strain grown under iron-starved conditions to stimulate transferrin receptor protein expression; selectively extracting aqueous soluble proteins; separation; solubilizing; purification mass |
| 02/20/2001 | US6190667 Contacting parental helicobacter strain with molecule in biological sample and contacting helicobacter strain deficient in urei gene with molecule; comparing acidity sensitivity of both strains; selecting molecule that increases acidity |
| 02/20/2001 | US6190666 Can be used to transform animal cells for use in efficient production of desired products, such as proteins and vaccines |
| 02/20/2001 | CA2206399C Method for secreting thrombopoietin polypeptides |
| 02/20/2001 | CA2199403C Novel pka-binding proteins and uses thereof |
| 02/20/2001 | CA2119651C Immunoassay for identifying alcoholics and monitoring alcohol consumption |
| 02/20/2001 | CA2043536C Tumor cell growth inhibitor |
| 02/20/2001 | CA2033730C Heparin-binding growth factor |
| 02/20/2001 | CA1341182C Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 02/20/2001 | CA1341181C Vaccines based on membrane bound proteins and process for making them |
| 02/15/2001 | WO2001011086A2 Methods of screening for angiogenesis modulators |
| 02/15/2001 | WO2001011057A1 Production of proteins |
| 02/15/2001 | WO2001011056A1 Production of proteins by autoproteolytic cleavage |
| 02/15/2001 | WO2001011050A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 02/15/2001 | WO2001011047A2 Dna sequences isolated from human colonic epithelial cells |
| 02/15/2001 | WO2001011046A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | WO2001011045A1 A human lactoferrin produced by using an insect cell and method using the same |
| 02/15/2001 | WO2001011040A1 Tumor-associated antigen (r11) |
| 02/15/2001 | WO2001011035A1 Monoclonal antibodies for human cytochrome p450 3a4 and human cytochrome p450 2c9 |
| 02/15/2001 | WO2001011027A1 New protein |
| 02/15/2001 | WO2001011021A1 Recombinant stabile cell clone, its production and use thereof |
| 02/15/2001 | WO2001011010A2 Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene |
| 02/15/2001 | WO2001010912A1 Multiple cytokine-antibody complexes |
| 02/15/2001 | WO2001010910A1 Diagnostic method using expression of mn/ca9 protein in ascus pap smears |
| 02/15/2001 | WO2001010909A1 Diagnostic method using expression of mn/ca9 protein in agus pap smears |
| 02/15/2001 | WO2001010902A2 Nucleoc acids and secreted polypeptides encoded thereby |
| 02/15/2001 | WO2001010889A1 Rat-g-protein coupled receptor brs3 |
| 02/15/2001 | WO2001010888A1 Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis |
| 02/15/2001 | WO2001010460A1 Treatment of intermediate- and high-grade non-hodgkins lymphoma with anti-cd20 antibody |
| 02/15/2001 | WO2000069886A3 Oligomeric chaperone proteins |
| 02/15/2001 | WO2000069884A3 Compositions isolated from skin cells and methods for their use |
| 02/15/2001 | WO2000068385A3 Novel nucleic acids and proteins with growth hormone activity |
| 02/15/2001 | WO2000068384A3 NOVEL NUCLEIC ACIDS AND PROTEINS WITH p53 ACTIVITY AND ALTERED TETRAMERIZATION DOMAINS |
| 02/15/2001 | WO2000068376B1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |
| 02/15/2001 | WO2000066709A3 Zymogen activation system |
| 02/15/2001 | WO2000066067A3 Ibd-associated microbial antigens and methods of using same |
| 02/15/2001 | WO2000065054A3 Human membrane-associated proteins |
| 02/15/2001 | WO2000064946A3 Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 02/15/2001 | WO2000063403A3 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein |
| 02/15/2001 | WO2000059933A3 HUMAN MESENCHYMAL DNAs AND EXPRESSION PRODUCTS |
| 02/15/2001 | WO2000044908A3 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins |
| 02/15/2001 | WO2000043419A3 Exocytosis pathway proteins and methods of use |